Lb Pharmaceuticals LBRX
NASDAQ LBRX
$40.81 -0.19 (-0.46%)
As of: Oct 21, 2026 · 10:20 AM EDT

Lb Pharmaceuticals (LBRX) EBITDA (2025 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted EBITDA of -$51.51 million for Q2 2026, compared with -$4.8 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EBITDA (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at Lb Pharmaceuticals was -$78.75 million; for FY2025, it came in at -$24.88 million.

  • In prior years, Lb Pharmaceuticals' EBITDA was -$63.01 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn 9.10 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn 8.33 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn -
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 5.89 Bn
10 Lb Pharmaceuticals 1.22 Bn -80.43 Mn - -51.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.51 Mn
Mar 31, 2026 -18.97 Mn
Sep 30, 2025 -3.48 Mn
Jun 30, 2025 -4.80 Mn
Mar 31, 2025 -5.23 Mn
API Access

Lb Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=LBRX&period=max&api_key=YOUR_API_KEY